Jiangsu Hengrui Pharmaceuticals Co., Ltd. (0BO)
FSX
Closed
Oct 7, 2026
Day's Range
5.4552 wk Range
4.82Overview - 0BO - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Key Statistics
Valuation
Enterprise Value
74.75M
P/E (Trailing)
‪37.66‬
Price / Sales (TTM)
‪1.15‬
Price / Book
‪4.57‬
EV / EBITDA
‪0.06‬
Profitability
Gross Margin
‪86.02%‬
Profit Margin
‪24.93%‬
Operating Margin
‪31.56%‬
Return on Assets
‪8.80%‬
Return on Equity
‪14.54%‬
Ownership
Shares Outstanding
6.63B
Float
3.77B
Held by Insiders
‪0.00%‬
Held by Institutions
‪71.27%‬
Price stats
Beta
‪0.04‬
50-Day Avg
‪5.53‬
200-Day Avg
‪6.66‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0BO - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Peers - 0BO - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.37.83BMarket Cap-75.44%52-week change37.67P/E (Trailing)‪24.93%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation109.81BMarket Cap+26.04%52-week change35.40P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.08BMarket Cap+13.03%52-week change25.79P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR58.69BMarket Cap+14.60%52-week change24.77P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG39.87BMarket Cap-1.16%52-week change54.63P/E (Trailing)‪14.57%‬Profit Margin
- H6D0FSXHaleon plc34.69BMarket Cap+4.33%52-week change18.79P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - 0BO - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
About
Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative medicines. Its current portfolio spans oncology, cardiovascular and metabolic diseases, autoimmune conditions, pain management, anti-infectives, and other…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
